Hemodynamic support of the micropreemie: Should hydrocortisone never be left out?

Area of Science:

• Neonatalogy
• Pediatric Cardiology
• Endocrinology

Background:

• Hemodynamic support is vital for preventing mortality and morbidity in micropreemies.
• Inadequate transition from fetal to neonatal circulation and insufficient cortisol production are key challenges.
• Immature and impaired myocardial function in the first 72 hours of life increases critical risks.

Purpose of the Study:

• To highlight the importance of appropriate hemodynamic management in micropreemies.
• To emphasize the role of functional echocardiography in adjusting circulatory parameters.
• To underscore the necessity of hydrocortisone for managing suboptimal perfusion and relative adrenal insufficiency.

Main Methods:

• Repeated functional echocardiography to assess and adjust preload, contractility, and afterload.
• Administration of hydrocortisone when myocardial function is unresponsive to initial hemodynamic management.
• Monitoring for signs of relative adrenal insufficiency and late-onset circulatory collapse.

Main Results:

• Appropriate adjustment of hemodynamic parameters using echocardiography is essential.
• Hydrocortisone effectively minimizes suboptimal perfusion burden in non-responsive cases.
• Early recognition and treatment of relative adrenal insufficiency are critical for preventing circulatory collapse.

Conclusions:

• Optimizing hemodynamic support through echocardiography and timely hydrocortisone administration is crucial for extremely preterm infants.
• Addressing the transition from fetal to neonatal circulation and potential cortisol inadequacy improves outcomes.
• Hydrocortisone therapy is vital for managing relative adrenal insufficiency and preventing circulatory collapse in this vulnerable population.